These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 27515187)

  • 1. Detection of cancer cells and tumor markers in gastric lavage of patients with gastric cancer: Do these findings have a clinicopathological significance and oncological implication?
    Virgilio E; Giarnieri E; Montagnini M; D'Urso R; Proietti A; Mesiti A; Giovagnoli MR; Mercantini P; Cavallini M; Balducci G
    Med Hypotheses; 2016 Sep; 94():1-3. PubMed ID: 27515187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing Gastric Lavage of Gastric Cancer Patients: A Prospective Observational Study on Cytopathology and Determination of Intragastric CEA, CA 19.9, CA 72.4, and CA 50.
    Virgilio E; Giarnieri E; Montagnini M; D''Urso R; Proietti A; Mesiti A; Giovagnoli MR; Mercantini P; Cavallini M; Balducci G
    Acta Cytol; 2016; 60(2):161-6. PubMed ID: 27096417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability.
    Virgilio E; Proietti A; D'Urso R; Cardelli P; Giarnieri E; Montagnini M; Giovagnoli MR; Mercantini P; Balducci G; Cavallini M
    Anticancer Res; 2017 Jun; 37(6):2817-2821. PubMed ID: 28551616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative gastric lavage in gastric cancer patients undergoing surgical, endoscopic or minimally invasive treatment: An oncological measure preventing peritoneal spillage of intragastric cancer cells and development of related metastases.
    Virgilio E; Balducci G; Mercantini P; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Cavallini M
    Med Hypotheses; 2018 May; 114():30-34. PubMed ID: 29602460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of metastasis-associated in colon cancer-1 and KAI1 in gastric adenocarcinoma and their clinical significance.
    Lu G; Zhou L; Zhang X; Zhu B; Wu S; Song W; Gong X; Wang D; Tao Y
    World J Surg Oncol; 2016 Oct; 14(1):276. PubMed ID: 27793161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
    Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ
    Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.
    Alakus H; Grass G; Hennecken JK; Bollschweiler E; Schulte C; Drebber U; Baldus SE; Metzger R; Hölscher AH; Mönig SP
    Histol Histopathol; 2008 Aug; 23(8):917-23. PubMed ID: 18498066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of GAGE gene can predict aggressive biologic behavior of intestinal type of stomach cancer.
    Kong U; Koo J; Choi K; Park J; Chang H
    Hepatogastroenterology; 2004; 51(59):1519-23. PubMed ID: 15362791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
    Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
    Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
    World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
    Hu X; Huang Z; Liao Z; He C; Fang X
    Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis.
    Sun A; Yu G; Dou X; Yan X; Yang W; Lin Q
    Mol Cancer; 2014 Nov; 13():248. PubMed ID: 25395181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
    Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
    Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
    Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients.
    Wang W; Seeruttun SR; Fang C; Chen J; Li Y; Liu Z; Zhan Y; Li W; Chen Y; Sun X; Li Y; Xu D; Guan Y; Zhou Z
    Ann Surg Oncol; 2016 Apr; 23(4):1244-51. PubMed ID: 26620645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach.
    Tajima Y; Yamazaki K; Makino R; Nishino N; Masuda Y; Aoki S; Kato M; Morohara K; Kusano M
    Br J Cancer; 2007 Feb; 96(4):631-8. PubMed ID: 17262083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of intraperitoneal CD44 mRNA levels of magnetically separated CD45-negative EpCAM-positive cells for peritoneal recurrence and prognosis in stage II and III gastric cancer patients.
    Horikawa M; Iinuma H; Inoue T; Ogawa E; Fukushima R
    Oncol Rep; 2011 May; 25(5):1413-20. PubMed ID: 21331451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
    Tseng CW; Yang JC; Chen CN; Huang HC; Chuang KN; Lin CC; Lai HS; Lee PH; Chang KJ; Juan HF
    Proteomics; 2011 Jun; 11(12):2423-39. PubMed ID: 21598387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.